Home > Insider Trading > Filing (0001209191-16-144650)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1674930	Fulgent Genetics Inc.	FLGT	Services-Medical Laboratories (8071)	812621304

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1684532	Hanlin Gao	C/O Fulgent Genetics, Inc. 4978 Santa Anita Avenue Temple City CA 91780	Chief Scientific Officer	No	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Predecessor Class D Voting Common Units	Disposition	2016-05-13	2,565,789	$1.17	13,434,211	No	4	S	Direct
Predecessor Class D Voting Common Units	Disposition	2016-09-30	13,434,211	$0.00	0	No	4	D	Direct
Issuer Common Stock	Acquisiton	2016-09-30	1,767,659	$0.00	1,767,659	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	D	Direct
No	4	A	Direct

Footnotes

Reflects securities of Fulgent Therapeutics LLC (the "Predecessor" or "Fulgent LLC"). Fulgent LLC is considered the predecessor of Fulgent Genetics, Inc. (the "Issuer") following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the "Reorganization"), which was completed on September 30, 2016 in connection with the initial public offering of the Issuer and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all of the Predecessor's Class D voting common units were cancelled in exchange for shares of the Issuer's common stock at a ratio of 7.6-for-1.
The securities were disposed of and cancelled in the Reorganization in exchange for 1,767,659 shares of the Issuer's common stock.
The securities were received in the Reorganization in exchange for the cancellation of 13,434,211 Class D voting common units of the Predecessor.